NCT00902460 - CP-690,550 and Midazolam Drug-Drug Interaction Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Healthy Volunteer

Interventions

DRUG

midazolam; CP-690,550 + midazolam

Period 1 : 2 mg midazolam oral syrup alone Period 2: 2 mg midazolam oral syrup plus 30 mg CP-690,550 after 6 days of CP-690,550 at 30 mg BID

DRUG

CP-690,550 + midazolam; midazolam

Period 1: 2 mg midazolam oral syrup plus 30 mg CP-690,550 after 6 days of CP-690,550 at 30 mg BID Period 2: 2 mg midazolam oral syrup alone

Trial Locations (1)

Pfizer Investigational Site, New Haven